全文获取类型
收费全文 | 1333262篇 |
免费 | 104970篇 |
国内免费 | 5956篇 |
专业分类
耳鼻咽喉 | 18916篇 |
儿科学 | 45078篇 |
妇产科学 | 36000篇 |
基础医学 | 189436篇 |
口腔科学 | 34505篇 |
临床医学 | 118615篇 |
内科学 | 266683篇 |
皮肤病学 | 28672篇 |
神经病学 | 103725篇 |
特种医学 | 53385篇 |
外国民族医学 | 712篇 |
外科学 | 202026篇 |
综合类 | 35015篇 |
现状与发展 | 20篇 |
一般理论 | 379篇 |
预防医学 | 99452篇 |
眼科学 | 29501篇 |
药学 | 100819篇 |
64篇 | |
中国医学 | 5400篇 |
肿瘤学 | 75785篇 |
出版年
2021年 | 11005篇 |
2019年 | 11134篇 |
2018年 | 15268篇 |
2017年 | 11782篇 |
2016年 | 12717篇 |
2015年 | 14979篇 |
2014年 | 20395篇 |
2013年 | 28919篇 |
2012年 | 40277篇 |
2011年 | 42743篇 |
2010年 | 25657篇 |
2009年 | 23984篇 |
2008年 | 39633篇 |
2007年 | 42257篇 |
2006年 | 42519篇 |
2005年 | 41456篇 |
2004年 | 39603篇 |
2003年 | 38414篇 |
2002年 | 37482篇 |
2001年 | 65093篇 |
2000年 | 67705篇 |
1999年 | 57727篇 |
1998年 | 16036篇 |
1997年 | 14610篇 |
1996年 | 14856篇 |
1995年 | 14056篇 |
1994年 | 13262篇 |
1993年 | 12110篇 |
1992年 | 44932篇 |
1991年 | 43788篇 |
1990年 | 42508篇 |
1989年 | 40366篇 |
1988年 | 37157篇 |
1987年 | 36427篇 |
1986年 | 33829篇 |
1985年 | 32433篇 |
1984年 | 24247篇 |
1983年 | 20356篇 |
1982年 | 11770篇 |
1981年 | 10735篇 |
1979年 | 21421篇 |
1978年 | 14858篇 |
1977年 | 12553篇 |
1976年 | 11704篇 |
1975年 | 12658篇 |
1974年 | 14706篇 |
1973年 | 14145篇 |
1972年 | 12964篇 |
1971年 | 11750篇 |
1970年 | 11063篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
92.
93.
R.D. Olmos R.C. de Figueiredo E.M. Aquino P.A. Lotufo I.M. Bensenor 《Brazilian journal of medical and biological research》2015,48(8):751-758
Thyroid diseases are common, and use of levothyroxine is increasing worldwide. We
investigated the influence of gender, race and socioeconomic status on the diagnosis
and treatment of thyroid disorders using data from the Brazilian Longitudinal Study
of Adult Health (ELSA-Brasil), a multicenter cohort study of civil servants (35-74
years of age) from six Brazilian cities. Diagnosis of thyroid dysfunction was by
thyrotropin (TSH), and free thyroxine (FT4) if TSH was altered, and the use of
specific medications. Multivariate logistic regression models were constructed using
overt hyperthyroidism/hypothyroidism and levothyroxine use as dependent variables and
sociodemographic characteristics as independent variables. The frequencies of overt
hyper- and hypothyroidism were 0.7 and 7.4%, respectively. Using whites as the
reference ethnicity, brown, and black race were protective for overt hypothyroidism
(OR=0.76, 95%CI=0.64-0.89, and OR=0.53, 95%CI=0.43-0.67, respectively, and black race
was associated with overt hyperthyroidism (OR=1.82, 95%CI=1.06-3.11). Frequency of
hypothyroidism treatment was higher in women, browns, highly educated participants
and those with high net family incomes. After multivariate adjustment, levothyroxine
use was associated with female gender (OR=6.06, 95%CI=3.19-11.49) and high net family
income (OR=3.23, 95%CI=1.02-10.23). Frequency of hyperthyroidism treatment was higher
in older than in younger individuals. Sociodemographic factors strongly influenced
the diagnosis and treatment of thyroid disorders, including the use of
levothyroxine. 相似文献
94.
95.
目的:探讨miR-26b参与原发性肝细胞肝癌(HCC)侵袭的机制。方法:在细胞培养液中培养人肝细胞系HL-7702和HCC细胞各系Hepb-3、HuH-7、MHCC97-L、MHCC97-H。实时荧光定量PCR法(qRT-PCR)检测miR-26b的表达水平;用miR-26b mimics、miR-26b inhibitors和Notch1-siRNA分别转染HCC细胞;MTT实验检测转染后HCC细胞的活力;采用Western blot检测Notch1受体蛋白表达水平的变化;Transwell小室测定不同处理后的HCC细胞的侵袭能力。结果:人正常肝细胞系HL-7702和HCC细胞系Hepb-3、HuH-7、MHCC97-L、MHCC97-H中的miR-26b相对表达含量随其侵袭和迁移能力的升高而依次下降;抑制miR-26b的表达,Notch1受体蛋白表达明显增高,而此时HCC细胞的侵袭性显著增强;相反,上调miR-26b的表达,Notch1受体蛋白表达明显降低,而HCC细胞侵袭性显著下降;miR-26b可能通过调控Notch1信号通路调节HCC细胞侵袭性。结论:miR-26b通过负调控Notch1信号通路抑制HCC细胞侵袭能力,为HCC侵袭的机制奠定了理论基础,miR-26b可能成为HCC治疗的新靶点。 相似文献
96.
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers 下载免费PDF全文
97.
Psoriasis is a chronic, inflammatory, immune‐mediated disease. Approximately 30% of patients have disease onset before age 18 years. Psoriasis in children and adolescents may be difficult to control, with subsequent poor quality of life and psychosocial consequences. We describe the case of a 12‐year‐old boy with severe, refractory, chronic plaque psoriasis for 6 years. Various therapeutic regimens including different topical corticosteroids, topical vitamin D analogs, phototherapy, photochemotherapy, systemic therapy with methotrexate, cyclosporin, and combination therapies showed only partial or transient responses with frequent relapses. Because anti‐interleukin‐12/23 agents have been successfully used in adults with psoriasis, ustekinumab was initiated and our patient showed a rapid, excellent, sustained response. No recurrence or flares have been observed after 33 months of follow‐up. This case illustrates that ustekinumab may be an effective and safe therapeutic option in adolescents with psoriasis. 相似文献
98.
99.
100.